Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Research output: Contribution to journalArticle

Abstract

Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

Original languageEnglish (US)
JournalJournal of Surgical Oncology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Neoplasms
Psychology
Costs and Cost Analysis
Health

Keywords

  • cancer
  • financial burden
  • financial distress
  • financial hardship
  • financial toxicity

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

@article{841f5a29f8074f7086543cd0188779cf,
title = "Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies",
abstract = "Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.",
keywords = "cancer, financial burden, financial distress, financial hardship, financial toxicity",
author = "Robert Lentz and {Benson III}, {Al B} and Kircher, {Sheetal Mehta}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/jso.25374",
language = "English (US)",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Financial toxicity in cancer care

T2 - Prevalence, causes, consequences, and reduction strategies

AU - Lentz, Robert

AU - Benson III, Al B

AU - Kircher, Sheetal Mehta

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

AB - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

KW - cancer

KW - financial burden

KW - financial distress

KW - financial hardship

KW - financial toxicity

UR - http://www.scopus.com/inward/record.url?scp=85060163595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060163595&partnerID=8YFLogxK

U2 - 10.1002/jso.25374

DO - 10.1002/jso.25374

M3 - Article

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

ER -